Akso Operating Cycle from 2010 to 2026

AHG Stock  USD 1.47  0.05  3.52%   
Akso Health's Operating Cycle is increasing over the last several years with stable swings. Operating Cycle is predicted to flatten to 353.01. During the period from 2010 to 2026 Akso Health Group Operating Cycle regressed destribution of quarterly values had coefficient of variationof  161.36 and r-value of  0.22. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
371.59
Current Value
353.01
Quarterly Volatility
1.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Selling General Administrative of 4 M or Selling And Marketing Expenses of 144 K, as well as many indicators such as Price To Sales Ratio of 30.39, Dividend Yield of 0.088 or PTB Ratio of 1.85. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
  
Build AI portfolio with Akso Stock
Check out the analysis of Akso Health Correlation against competitors.
The Operating Cycle trend for Akso Health Group offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Akso Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Akso Health's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Akso Health Group over the last few years. It is Akso Health's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akso Health's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

Akso Operating Cycle Regression Statistics

Arithmetic Mean709.14
Geometric Mean176.66
Coefficient Of Variation161.36
Mean Deviation878.71
Median99.76
Standard Deviation1,144
Sample Variance1.3M
Range3.6K
R-Value0.22
Mean Square Error1.3M
R-Squared0.05
Significance0.39
Slope50.12
Total Sum of Squares20.9M

Akso Operating Cycle History

2026 353.01
2025 371.59
2024 323.12
2023 30.45
2022 307.14
2021 1744.11
2020 2995.19

About Akso Health Financial Statements

Akso Health stakeholders use historical fundamental indicators, such as Akso Health's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 371.59  353.01 

Currently Active Assets on Macroaxis

When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:
Check out the analysis of Akso Health Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Akso have expansion opportunities? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Akso Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(0.48)
Revenue Per Share
0.052
Quarterly Revenue Growth
4.158
Return On Assets
(0.01)
Return On Equity
(0.80)
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Akso Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Akso Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Akso Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.